These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 29722149)

  • 1. Fragment-Based Phenotypic Lead Discovery: Cell-Based Assay to Target Leishmaniasis.
    Ayotte Y; Bilodeau F; Descoteaux A; LaPlante SR
    ChemMedChem; 2018 Jul; 13(14):1377-1386. PubMed ID: 29722149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A screen against Leishmania intracellular amastigotes: comparison to a promastigote screen and identification of a host cell-specific hit.
    De Muylder G; Ang KK; Chen S; Arkin MR; Engel JC; McKerrow JH
    PLoS Negl Trop Dis; 2011 Jul; 5(7):e1253. PubMed ID: 21811648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High content analysis of primary macrophages hosting proliferating Leishmania amastigotes: application to anti-leishmanial drug discovery.
    Aulner N; Danckaert A; Rouault-Hardoin E; Desrivot J; Helynck O; Commere PH; Munier-Lehmann H; Späth GF; Shorte SL; Milon G; Prina E
    PLoS Negl Trop Dis; 2013; 7(4):e2154. PubMed ID: 23593521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragment-based screening in tandem with phenotypic screening provides novel antiparasitic hits.
    Blaazer AR; Orrling KM; Shanmugham A; Jansen C; Maes L; Edink E; Sterk GJ; Siderius M; England P; Bailey D; de Esch IJ; Leurs R
    J Biomol Screen; 2015 Jan; 20(1):131-40. PubMed ID: 25231971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of NanoLuc-PEST expressing Leishmania mexicana as a new drug discovery tool for axenic- and intramacrophage-based assays.
    Berry SL; Hameed H; Thomason A; Maciej-Hulme ML; Saif Abou-Akkada S; Horrocks P; Price HP
    PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006639. PubMed ID: 30001317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of synthetic substituted 1,2-dioxanes as novel agents against human leishmaniasis.
    Ortalli M; Varani S; Rosso C; Quintavalla A; Lombardo M; Trombini C
    Eur J Med Chem; 2019 May; 170():126-140. PubMed ID: 30878827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repurposing of the Open Access Malaria Box for Kinetoplastid Diseases Identifies Novel Active Scaffolds against Trypanosomatids.
    Kaiser M; Maes L; Tadoori LP; Spangenberg T; Ioset JR
    J Biomol Screen; 2015 Jun; 20(5):634-45. PubMed ID: 25690568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human African trypanosomiasis, leishmaniasis, and Chagas disease.
    Annang F; Pérez-Moreno G; García-Hernández R; Cordon-Obras C; Martín J; Tormo JR; Rodríguez L; de Pedro N; Gómez-Pérez V; Valente M; Reyes F; Genilloud O; Vicente F; Castanys S; Ruiz-Pérez LM; Navarro M; Gamarro F; González-Pacanowska D
    J Biomol Screen; 2015 Jan; 20(1):82-91. PubMed ID: 25332350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antichagasic, Leishmanicidal, and Trichomonacidal Activity of 2-Benzyl-5-nitroindazole-Derived Amines.
    Fonseca-Berzal C; Ibáñez-Escribano A; Vela N; Cumella J; Nogal-Ruiz JJ; Escario JA; da Silva PB; Batista MM; Soeiro MNC; Sifontes-Rodríguez S; Meneses-Marcel A; Gómez-Barrio A; Arán VJ
    ChemMedChem; 2018 Jun; 13(12):1246-1259. PubMed ID: 29624912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel Leishmania major amastigote assay in 96-well format for rapid drug screening and its use for discovery and evaluation of a new class of leishmanicidal quinolinium salts.
    Bringmann G; Thomale K; Bischof S; Schneider C; Schultheis M; Schwarz T; Moll H; Schurigt U
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3003-11. PubMed ID: 23587955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel steroid derivatives: synthesis, antileishmanial activity, mechanism of action, and in silico physicochemical and pharmacokinetics studies.
    da Trindade Granato J; Dos Santos JA; Calixto SL; Prado da Silva N; da Silva Martins J; da Silva AD; Coimbra ES
    Biomed Pharmacother; 2018 Oct; 106():1082-1090. PubMed ID: 30119174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Auranofin is an apoptosis-simulating agent with in vitro and in vivo anti-leishmanial activity.
    Sharlow ER; Leimgruber S; Murray S; Lira A; Sciotti RJ; Hickman M; Hudson T; Leed S; Caridha D; Barrios AM; Close D; Grögl M; Lazo JS
    ACS Chem Biol; 2014 Mar; 9(3):663-72. PubMed ID: 24328400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of potent chemotypes targeting Leishmania major using a high-throughput, low-stringency, computationally enhanced, small molecule screen.
    Sharlow ER; Close D; Shun T; Leimgruber S; Reed R; Mustata G; Wipf P; Johnson J; O'Neil M; Grögl M; Magill AJ; Lazo JS
    PLoS Negl Trop Dis; 2009 Nov; 3(11):e540. PubMed ID: 19888337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cysteine proteases as potential targets for anti-trypanosomatid drug discovery.
    Judice WAS; Ferraz LS; Lopes RM; Vianna LDS; Siqueira FDS; Di Iorio JF; Dalzoto LAM; Trujilho MNR; Santos TDR; Machado MFM; Rodrigues T
    Bioorg Med Chem; 2021 Sep; 46():116365. PubMed ID: 34419821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a Focused Library of Triazole-Linked Privileged-Structure-Based Conjugates Leading to the Discovery of Novel Phenotypic Hits against Protozoan Parasitic Infections.
    Uliassi E; Piazzi L; Belluti F; Mazzanti A; Kaiser M; Brun R; Moraes CB; Freitas-Junior LH; Gul S; Kuzikov M; Ellinger B; Borsari C; Costi MP; Bolognesi ML
    ChemMedChem; 2018 Apr; 13(7):678-683. PubMed ID: 29451361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fishing for anti-leishmania drugs: principles and problems.
    Handman E; Kedzierski L; Uboldi AD; Goding JW
    Adv Exp Med Biol; 2008; 625():48-60. PubMed ID: 18365658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Validation of a Novel Leishmania donovani Screening Cascade for High-Throughput Screening Using a Novel Axenic Assay with High Predictivity of Leishmanicidal Intracellular Activity.
    Nühs A; De Rycker M; Manthri S; Comer E; Scherer CA; Schreiber SL; Ioset JR; Gray DW
    PLoS Negl Trop Dis; 2015 Sep; 9(9):e0004094. PubMed ID: 26407168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of new leishmanicidal peptide lead structures by automated real-time monitoring of changes in intracellular ATP.
    Luque-Ortega JR; Saugar JM; Chiva C; Andreu D; Rivas L
    Biochem J; 2003 Oct; 375(Pt 1):221-30. PubMed ID: 12864731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmanicidal, antiproteolytic, and mutagenic evaluation of alkyltriazoles and alkylphosphocholines.
    Gontijo VS; Espuri PF; Alves RB; de Camargos LF; Santos FV; de Souza Judice WA; Marques MJ; Freitas RP
    Eur J Med Chem; 2015 Aug; 101():24-33. PubMed ID: 26112378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leishmanicidal effects of piperine, its derivatives, and analogues on Leishmania amazonensis.
    Ferreira C; Soares DC; Barreto-Junior CB; Nascimento MT; Freire-de-Lima L; Delorenzi JC; Lima ME; Atella GC; Folly E; Carvalho TM; Saraiva EM; Pinto-da-Silva LH
    Phytochemistry; 2011 Dec; 72(17):2155-64. PubMed ID: 21885074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.